Kiora Pharmaceuticals, Inc. (KPRX) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Kiora Pharmaceuticals, Inc. (KPRX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Kiora Pharmaceuticals, Inc., analysts forecast revenue rising from $1.50M in 2025 to $52.90M in 2030; the average estimate for 2030 earnings per share is −$1.25; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Kiora Pharmaceuticals, Inc. (KPRX) forecast — frequently asked questions
What are analysts forecasting for Kiora Pharmaceuticals, Inc.'s earnings?
The average analyst estimate for Kiora Pharmaceuticals, Inc. (KPRX) earnings per share in 2030 is -1.25, with individual estimates between -1.25 and -1.25.
How much revenue is Kiora Pharmaceuticals, Inc. expected to make?
Analysts forecast Kiora Pharmaceuticals, Inc. (KPRX) revenue of $52.90M in 2030, based on 1 published estimates.
How many analysts cover KPRX?
1 analyst contribute estimates for Kiora Pharmaceuticals, Inc. (KPRX). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.